» Articles » PMID: 17178846

Tumor Necrosis Factor-alpha is a Potent Endogenous Mutagen That Promotes Cellular Transformation

Overview
Journal Cancer Res
Specialty Oncology
Date 2006 Dec 21
PMID 17178846
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor necrosis factor-alpha (TNF-alpha) is an important inflammation cytokine without known direct effect on DNA. In this study, we found that TNF-alpha can cause DNA damages through reactive oxygen species. The mutagenic effect of TNF-alpha is comparable with that of ionizing radiation. TNF-alpha treatment in cultured cells resulted in increased gene mutations, gene amplification, micronuclei formation, and chromosomal instability. Antioxidants significantly reduced TNF-alpha-induced genetic damage. TNF-alpha also induced oxidative stress and nucleotide damages in mouse tissues in vivo. Moreover, TNF-alpha treatment alone led to increased malignant transformation of mouse embryo fibroblasts, which could be partially suppressed by antioxidants. As TNF-alpha is involved in chronic inflammatory diseases, such as chronic hepatitis, ulcerative colitis, and chronic skin ulcers, and these diseases predispose the patients to cancer development, our results suggest a novel pathway through which TNF-alpha promotes cancer development through induction of gene mutations, in addition to the previously reported mechanisms, in which nuclear factor-kappaB activation was implicated.

Citing Articles

Obesity increases DNA damage in the breast epithelium.

Gaber M, Quentel A, Holmes J, Lepetit C, Triki H, Wilson A Breast Cancer Res. 2025; 27(1):11.

PMID: 39838489 PMC: 11753040. DOI: 10.1186/s13058-025-01961-7.


Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.

Liu S, Zhang X, Wang W, Li X, Sun X, Zhao Y Mol Cancer. 2024; 23(1):261.

PMID: 39574178 PMC: 11580516. DOI: 10.1186/s12943-024-02165-x.


Friend or Foe: Exploring the Relationship between the Gut Microbiota and the Pathogenesis and Treatment of Digestive Cancers.

Profir M, Rosu O, Cretoiu S, Gaspar B Microorganisms. 2024; 12(5).

PMID: 38792785 PMC: 11124004. DOI: 10.3390/microorganisms12050955.


Potential noninvasive biomarkers for the malignant transformation of oral leukoplakia: A systematic review and meta-analysis.

Huang Y, Zhang Q, Guo Z, Deng G, Chen R, Zheng Y Cancer Med. 2023; 12(13):14718-14730.

PMID: 37199052 PMC: 10358244. DOI: 10.1002/cam4.6095.


Fatal Progression of Mutated TP53-Associated Clonal Hematopoiesis following Anti-CD19 CAR-T Cell Therapy.

Eder L, Martinovic D, Mazzeo P, Ganster C, Hasenkamp J, Thomson J Curr Oncol. 2023; 30(1):1146-1150.

PMID: 36661736 PMC: 9858310. DOI: 10.3390/curroncol30010087.